Estimation of apparent tumor vascular permeability from multiphoton fluorescence microscopic images of P22 rat sarcomas in vivo

Microcirculation

Volumn 15, Issue 1, 2008, Pages 65-79

  Reyes Aldasoro, Constantino Carlos ^a   Wilson, Ian ^b   Prise, Vivien ^b   Barber, Paul R ^b   Ameer Beg, Simon M ^d   Vojnovic, Borivoj ^b   Cunningham, Vincent J ^c   Tozer, Gillian M ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b MOUNT VERNON HOSPITAL   (United Kingdom)

^c GLAXOSMITHKLINE   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Combretastatin; Multiphoton fluorescence microscopy; Segmentation; Tumor vascular disrupting agents; Vascular permeability

Indexed keywords

COMBRETASTATIN A4 PHOSPHATE; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; EXTRAVASATION; IMAGE PROCESSING; IN VIVO STUDY; MACROMOLECULE; MALE; METHODOLOGY; MICROVASCULATURE; MULTIPHOTON MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; SARCOMA; SKIN FLAP; TUMOR BLOOD FLOW; TUMOR VASCULARIZATION; TUMOR VOLUME;

ALGORITHMS; ANIMALS; CAPILLARY PERMEABILITY; DEXTRANS; FLUORESCEIN-5-ISOTHIOCYANATE; IMAGE PROCESSING, COMPUTER-ASSISTED; MICROCIRCULATION; MICROSCOPY, FLUORESCENCE; NEOPLASM TRANSPLANTATION; NEOPLASMS, CONNECTIVE TISSUE; NEOVASCULARIZATION, PATHOLOGIC; RATS; RATS, INBRED STRAINS; SARCOMA;

RATTUS;

EID: 38049100658     PISSN: 10739688     EISSN: 15498719     Source Type: Journal    
DOI: 10.1080/10739680701436350     Document Type: Article

References (35)

1. Jain, R. K. (1989) Delivery of novel therapeutic agents into tumours: physiological barriers and strategies. JNCI, 81, pp. 570-576.
2. Monsky, W. L., Carreira, C Mouta, Tsuzuki, Y., Gohongi, T., Fukumura, D. and Jain, R. K. (2002) Role of host microenvironment in angiogenesis and microvascular functions in human breast cancer xenografts: Mammary fat pad versus cranial tumors. Clin Cancer Res, 8, pp. 1008-1013.
3. Tozer, G. M., Kanthou, C. and Baguley, B. C. (2005) Disrupting tumour blood vessels. Nat Rev Cancer, 5, pp. 423-435.
4. McDonald, D. M. and Baluk, P. (2002) Significance of blood vessel leakiness in cancer. Cancer Res, 62, pp. 5381-5385.
5. Baird, L. C., Canoll, P. and Bruce, J. (2003) Effect of infiltrating tumor cells on the blood-brain barrier in a neonatal rat glioma model. Society for Neuro-Oncology Eighth Annual Meeting Keystone, Colorado
6. Nakano, S., Matsukado, K. and Black, K. L. (1996) Increase brain tumor microvessel permeability after intracarotid bradykinin infusion is mediated by nitric oxide. Cancer Res, 56, pp. 4027-4031.
7. Inoue, N., Venema, R. C., Sayegh, H. S., Ohara, Y., Murphy, T. J. and Harrison, D. G. (1995) Molecular regulation of the bovine endothelial nitric oxide synthase by transforming growth factor-beta 1. Arterioscler Thromb Vasc Biol, 15, pp. 1255-1261.
8. Masters, B. R. and So, P TC (2004) Antecedents of two-photon excitation laser scanning microscopy, microscopy research and technique. Microsc Res Tech, 63, pp. 3-11.
9. Yuan, F., Leunig, M., Berk, D. A. and Jain, R. K. (1993) Microvascular permeability of albumin, vascular surface area, and vascular volume measured in human adenocarcinoma LS174T using dorsal chamber in SCID mice. Microvasc Res, 45, pp. 269-289.
10. Dark, G. D., Hill, S. A., Prise, V. E., Tozer, G. M., Pettit, G. R. and Chaplin, D. J. (1997) Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature. Cancer Res, 57, pp. 1829-1834.
11. Grosios, K., Holwell, S. E., McGown, A. T., Pettit, G. R. and Bibby, M. C. (1999) In vivo and in vitro evaluation of combretastatin A-4 and its sodium phosphate prodrug. Br J Cancer, 81, pp. 1318-1327.
12. Tozer, G. M., Prise, V. E., Wilson, J., Cemazar, M., Shan, S., Dewhirst, M. W., Barber, P. R., Vojnovic, B. and Chaplin, D. J. (2001) Mechanisms associated with tumor vascular shut-down induced by combretastatin A-4 phosphate: Intravital microscopy and measurement of vascular permeability. Cancer Res, 61, pp. 6413-6422.
13. Tozer, G. M., Prise, V. E., Wilson, J., Locke, R. J., Vojnovic, B., Stratford, M RL, Dennis, M. F. and Chaplin, D. J. (1999) Combretastatin A-4 phosphate as a tumor vascular-targeting agent: Early effects in tumors and normal tissues. Cancer Res, 59, pp. 1626-1634.
14. Kanthou, C. and Tozer, G. M. (2002) The tumor vascular targeting agent combretastatin A-4-phosphate induces reorganization of the actin cytoskeleton and early membrane blebbing in human endothelial cells. Blood, 99, pp. 2060-2069.
15. Gaede, V. and Günther, O. (1998) Multidimensional access methods. ACM Computing Surveys, 30, pp. 170-231.
16. de Castro, E. and Morandi, C. (1987) Registration of translated and rotated images using finite Fourier transforms. IEEE Trans Pattern Anal Mach Intell, 5, pp. 700-703.
17. Hill, D LG, Batchelor, P. G., Holden, M. and Hawkes, D. J. (2001) Medical image registration [invited topical review]. Phys Med Biol, 46, pp. R1-R45.
18. Randen, T. and Husøy, J. H. (1999) Filtering for texture classification: A comparative study. IEEE Trans Pattern Anal Mach Intell, 21, pp. 291-310.
19. Schroeter, P. and Bigun, J. (1999) Hierarchical image segmentation by multi-dimensional clustering and orientation-adaptive boundary refinement. Pattern Recognition, 28, pp. 695-709.
20. Patlak, C. S., Blasberg, R. G. and Fenstermacher, J. D. (1983) Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab, 3, pp. 1-7.
21. Padhani, A. R. and Choyke, P. L. (2006) New Techniques in Oncologic Imaging, CRC Press, Boca Raton, FL
22. Daldrup, H., Shames, D. M., Wendland, M., Okuhata, Y., Link, T. M., Rosenau, W., Lu, Y. and Brasch, R. C. (1998) Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: Comparison of macromolecular and small-molecular contrast media. Am J Roentgenol, 171, pp. 941-949.
23. Daldrup, H. E., Shames, D. M., Husseini, W., Wendland, M. F., Okuhata, Y. and Brasch, R. C. (1998) Quantification of the extraction fraction for gadopentetate across breast cancer capillaries. Magn Reson Med, 40, pp. 537-543.
24. Roberts, H. C., Roberts, T. P., Ley, S., Dillon, W. P. and Brasch, R. C. (2002) Quantitative estimation of microvascular permeability in human brain tumors: Correlation of dynamic Gd-DTPA-enhanced MR imaging with histopathologic grading. Acad Radiol, 9, pp. S151-S155.
25. Romer, W., Hanauske, A. R., Ziegler, S., Thodtmann, R., Weber, W., Fuchs, C., Enne, W., Herz, M., Nerl, C., Garbrecht, M. and Schwaiger, M. (1998) Positron emission tomography in non-Hodgkin's lymphoma: assessment of chemotherapy with fluorodeoxyglucose. Blood, 91, pp. 4464-4471.
26. Smith, I. C., Welch, A. E., Hutcheon, A. W., Miller, I. D., Payne, S., Chilcott, F., Waikar, S., Whitaker, T., Ah-See, A. K., Eremin, O., Heys, S. D., Gilbert, F. J. and Sharp, P. F. (2000) Positron emission tomography using [(18)F]-fluorodeoxy-77D-glucose to predict the pathologic response of breast cancer to primary chemotherapy. J Clin Oncol, 18, pp. 1676-1688.
27. Lodge, M. A., Lucas, J. D., Marsden, P. K., Cronin, B. F., O'Doherty, M. J. and Smith, M. A. (1999) A PET study of 18FDG uptake in soft tissue masses. Eur J Nucl Med, 26, pp. 22-30.
28. Vesselle, H., Schmidt, R. A., Pugsley, J. M., Li, M., Kohlmyer, S. G., Vallires, E. and Wood, D. E. (2000) Lung cancer proliferation correlates with [F-18]fluorodeoxyglucose uptake by positron emission tomography. Clin Cancer Res, 6, pp. 3837-3844.
29. Renkin, E. M. (1959) Transport of potassium-42 from blood to tissue in isolated mammalian skeletal muscles. Am J Physiol, 197, pp. 1205-1210.
30. Michel, C. C. and Curry, F. E. (1999) Microvascular permeability. Physiol Rev, 79, pp. 703-761.
31. Bickel, U. (2005) How to measure drug transport across the blood-brain barrier. NeuroRx, 2, pp. 15-26.
32. Gerlowski, L. E. and Jain, R. K. (1986) Microvascular permeability of normal and neoplastic tissues. Microvasc Res, 31, pp. 288-305.
33. Prise, V. E., Honess, D. J., Stratford, M RL, Wilson, J. and Tozer, G. M. (2002) The vascular response of tumor and normal tissues in the rat to the vascular targeting agent, combretastatin A-4-phosphate, at clinically relevant doses. Int J Oncol, 21, pp. 717-726.
34. Briseid, G. and Briseid, K. (1983) Inhibition by low molecular weight dextran of the blood pressure fall and the lowering of plasminogen proactivator induced by clinical dextran in the rat. Acta Pharmacol Toxicol (Copenh), 52, pp. 143-149.
35. Prise, V. E., Honess, D. J., Stratford, M RL, Wilson, J. and Tozer, G. M. (2002) The vascular response of tumor and normet tissues in the rat to the vascular targeting agent, combretastatin A-4-phosphate, at clinically relevant doses. Int J Oncol, 2, pp. 717-726.